Inhibition of apoptotic Bax translocation to the mitochondria is a central function of parkin

Cell Death and Disease

Volumn 5, Issue 7, 2014, Pages

  Charan, R A ^a   Johnson, B N ^a,b   Zaganelli, S ^b   Nardozzi, J D ^a,b   LaVoie, M J ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BH3 PROTEIN; CARBONYL CYANIDE CHLOROPHENYLHYDRAZONE; CASPASE 3; LYSINE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PARKIN; PROTEIN BAX; STAUROSPORINE; TRANSLOCASE OF OUTER MITOCHONDRIAL MEMBRANE 20; VOLTAGE DEPENDENT ANION CHANNEL; PROTEIN BINDING; UBIQUITIN PROTEIN LIGASE;

ANIMAL CELL; APOPTOSIS; ARTICLE; ASTROCYTE; ASTROCYTE CULTURE; BRAIN; BRAIN CELL; CELL DEATH; CELL FRACTIONATION; CELL IMMORTALIZATION; CELL LYSATE; CONTROLLED STUDY; CYTOSOL; CYTOSOLIC FRACTION; DOPAMINERGIC NERVE CELL; EMBRYO; ENZYME ACTIVITY; GENE TRANSLOCATION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; IMMUNOPRECIPITATION; KIDNEY CELL; LOSS OF FUNCTION MUTATION; MISSENSE MUTATION; MITOCHONDRIAL DYNAMICS; MITOCHONDRION; MITOPHAGY; MOUSE; NERVE CELL CULTURE; NEWBORN; NONHUMAN; PRIMARY CELL; PRIMARY CULTURE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INTERACTION; PROTEIN SECONDARY STRUCTURE; RAT; REGULATORY MECHANISM; STRESS; SUBSTANTIA NIGRA; UBIQUITINATION; CELL CULTURE; CHEMISTRY; CYTOLOGY; DOWN REGULATION; GENETICS; METABOLISM; NERVE CELL; PARKINSON DISEASE; PATHOPHYSIOLOGY; PROTEIN MOTIF; PROTEIN TRANSPORT;

AMINO ACID MOTIFS; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; CELLS, CULTURED; DOWN-REGULATION; HUMANS; MITOCHONDRIA; NEURONS; PARKINSON DISEASE; PROTEIN BINDING; PROTEIN TRANSPORT; UBIQUITIN-PROTEIN LIGASES;

EID: 84905437927     PISSN: None     EISSN: 20414889     Source Type: Journal    
DOI: 10.1038/cddis.2014.278     Document Type: Article

References (65)

1. Kitada T, Asakawa S, Hattori N, Matsumine H, Yamamura Y, Minoshima S et al. Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. Nature 1998; 392: 605-608
2. Berger AK, Cortese GP, Amodeo KD, Weihofen A, Letai A, LaVoie MJ. Parkin selectively alters the intrinsic threshold for mitochondrial cytochrome c release. Hum Mol Genet 2009; 18: 4317-4328
3. Johnson BN, Berger AK, Cortese GP, LaVoie MJ. The ubiquitin E3 ligase parkin regulates the proapoptotic function of Bax. Proc Natl Acad Sci USA 2012; 109: 6283-6288
4. Greene JC, Whitworth AJ, Kuo I, Andrews LA, Feany MB, Pallanck LJ. Mitochondrial pathology and apoptotic muscle degeneration in Drosophila parkin mutants. Proc Natl Acad Sci USA 2003; 100: 4078-4083
5. Pesah Y, Pham T, Burgess H, Middlebrooks B, Verstreken P, Zhou Y et al. Drosophila parkin mutants have decreased mass and cell size and increased sensitivity to oxygen radical stress. Development 2004; 131: 2183-2194
6. Darios F, Corti O, Lucking CB, Hampe C, Muriel MP, Abbas N et al. Parkin prevents mitochondrial swelling and cytochrome c release in mitochondria- dependent cell death. Hum Mol Genet 2003; 12: 517-526
7. Kemeny S, Dery D, Loboda Y, Rovner M, Lev T, Zuri D et al. Parkin promotes degradation of the mitochondrial pro-apoptotic ARTS protein. PLoS One 2012; 7: e38837
8. Narendra D, Tanaka A, Suen D-F, Youle RJ. Parkin is recruited selectively to impaired mitochondria and promotes their autophagy. J Cell Biol 2008; 183: 795-803
9. Narendra DP, Jin SM, Tanaka A, Suen D-F, Gautier CA, Shen J et al. PINK1 is selectively stabilized on impaired mitochondria to activate Parkin. PLoS Biol 2010; 8: e1000298
10. Jurgensmeier JM, Xie Z, Deveraux Q, Ellerby L, Bredesen D, Reed JC. Bax directly induces release of cytochrome c from isolated mitochondria. Proc Natl Acad Sci USA 1998; 95: 4997-5002
11. Muller-Rischart AK, Pilsl A, Beaudette P, Patra M, Hadian K, Funke M et al. The E3 ligase parkin maintains mitochondrial integrity by increasing linear ubiquitination of NEMO. Mol Cell 2013; 49: 908-921
12. Sarraf SA, Raman M, Guarani-Pereira V, Sowa ME, Huttlin EL, Gygi SP et al. Landscape of the PARKIN-dependent ubiquitylome in response to mitochondrial depolarization. Nature 2013; 496: 372-376
13. Matsuda N, Sato S, Shiba K, Okatsu K, Saisho K, Gautier CA et al. PINK1 stabilized by mitochondrial depolarization recruits Parkin to damaged mitochondria and activates latent Parkin for mitophagy. J Cell Biol 2010; 189: 211-221
14. Yoshii SR, Kishi C, Ishihara N, Mizushima N. Parkin mediates proteasome-dependent protein degradation and rupture of the outer mitochondrial membrane. J Biol Chem 2011; 286: 19630-19640
15. Wang H, Song P, Du L, Tian W, Yue W, Liu M et al. Parkin ubiquitinates Drp1 for proteasome-dependent degradation: implication of dysregulated mitochondrial dynamics in Parkinson disease. J Biol Chem 2011; 286: 11649-11658
16. Cai Q, Zakaria HM, Simone A, Sheng Z-H. Spatial parkin translocation and degradation of damaged mitochondria via mitophagy in live cortical neurons. Curr Biol 2012; 22: 545-552
17. Sterky FH, Lee S, Wibom R, Olson L, Larsson NG. Impaired mitochondrial transport and Parkin-independent degeneration of respiratory chain-deficient dopamine neurons in vivo. Proc Natl Acad Sci USA 2011; 108: 12937-12942
18. Lee S, Sterky FH, Mourier A, Terzioglu M, Cullheim S, Olson L et al. Mitofusin 2 is necessary for striatal axonal projections of midbrain dopamine neurons. Hum Mol Genet 2012; 21: 4827-4835
19. Van Laar VS, Arnold B, Cassady SJ, Chu CT, Burton EA, Berman SB. Bioenergetics of neurons inhibit the translocation response of Parkin following rapid mitochondrial depolarization. Hum Mol Genet 2011; 20: 927-940
20. Casarejos MJ, Menendez J, Solano RM, Rodriguez-Navarro JA, J. Garcia de Yebenes, Mena MA. Susceptibility to rotenone is increased in neurons from parkin null mice and is reduced by minocycline. J Neurochem 2006; 97: 934-946
21. Crawford GD, Le WD, Smith RG, Xie WJ, Stefani E, Appel SH. A novel N18TG2 x mesencephalon cell hybrid expresses properties that suggest a dopaminergic cell line of substantia nigra origin. J Neurosci 1992; 12: 3392-3398
22. LaVoie MJ, Ostaszewski BL, Weihofen A, Schlossmacher MG, Selkoe DJ. Dopamine covalently modifies and functionally inactivates parkin. Nat Med 2005; 11: 1214-1221
23. Henn IH, Bouman L, Schlehe JS, Schlierf A, Schramm JE, Wegener E et al. Parkin mediates neuroprotection through activation of IkappaB kinase/nuclear factor-kappaB signaling. J Neurosci 2007; 27: 1868-1878
24. Vincow ES, Merrihew G, Thomas RE, Shulman NJ, Beyer RP, MacCoss MJ et al. The PINK1-Parkin pathway promotes both mitophagy and selective respiratory chain turnover in vivo. Proc Natl Acad Sci USA 2013; 110: 6400-6405
25. McLelland GL, Soubannier V, Chen CX, McBride HM, Fon EA. Parkin and PINK1 function in a vesicular trafficking pathway regulating mitochondrial quality control. EMBO J 2014; 33: 282-295
26. Chan NC, Salazar AM, Pham AH, Sweredoski MJ, Kolawa NJ, Graham RL et al. Broad activation of the ubiquitin-proteasome system by Parkin is critical for mitophagy. Hum Mol Genet 2011; 20: 1726-1737
27. da Costa CA, Sunyach C, Giaime E, West A, Corti O, Brice A et al. Transcriptional repression of p53 by parkin and impairment by mutations associated with autosomal recessive juvenile Parkinson's disease. Nat Cell Biol 2009; 11: 1370-1375
28. Duplan E, Sevalle J, Viotti J, Goiran T, Bauer C, Renbaum P et al. Parkin differently regulates presenilin-1 and presenilin-2 functions by direct control of their promoter transcription. J Mol Cell Biol 2013; 5: 132-142
29. Viotti J, Duplan E, Caillava C, Condat J, Goiran T, Giordano C et al. Glioma tumor grade correlates with parkin depletion in mutant p53-linked tumors and results from loss of function of p53 transcriptional activity. Oncogene 2013; 33: 1764-1775
30. Bosco DA, LaVoie MJ, Petsko GA, Ringe D. Proteostasis and movement disorders: Parkinson's disease and amyotrophic lateral sclerosis. Cold Spring Harb Perspect Biol 2011; 3: a007500
31. George NM, Evans JJD, Luo X. A three-helix homo-oligomerization domain containing BH3 and BH1 is responsible for the apoptotic activity of Bax. Genes Dev 2007; 21: 1937-1948
32. Chen D, Gao F, Li B, Wang H, Xu Y, Zhu C et al. Parkin mono-ubiquitinates Bcl-2 and regulates autophagy. J Biol Chem 2010; 285: 38214-38223
33. Ding WX, Ni HM, Li M, Liao Y, Chen X, Stolz DB et al. Nix is critical to two distinct phases of mitophagy, reactive oxygen species-mediated autophagy induction and Parkin-ubiquitinp62- mediated mitochondrial priming. J Biol Chem 2010; 285: 27879-27890
34. Qiu XB, Goldberg AL. Nrdp1/FLRF is a ubiquitin ligase promoting ubiquitination and degradation of the epidermal growth factor receptor family member, ErbB3. Proc Natl Acad Sci USA 2002; 99: 14843-14848
35. Sriram SR, Li X, Ko HS, Chung KK, Wong E, Lim KL et al. Familial-associated mutations differentially disrupt the solubility, localization, binding and ubiquitination properties of parkin. Hum Mol Genet 2005; 14: 2571-2586
36. Schlehe JS, Lutz AK, Pilsl A, Lammermann K, Grgur K, Henn IH et al. Aberrant folding of pathogenic Parkin mutants: aggregation versus degradation. J Biol Chem 2008; 283: 13771-13779
37. Suzuki M, Youle RJ, Tjandra N. Structure of Bax: coregulation of dimer formation and intracellular localization. Cell 2000; 103: 645-654
38. Wolter KG, Hsu YT, Smith CL, Nechushtan A, Xi XG, Youle RJ. Movement of Bax from the cytosol to mitochondria during apoptosis. J Cell Biol 1997; 139: 1281-1292
39. Nechushtan A, Smith CL, Hsu YT, Youle RJ. Conformation of the Bax C-terminus regulates subcellular location and cell death. EMBOJ 1999; 18: 2330-2341
40. Abbas N, Lucking CB, Ricard S, Durr A, Bonifati V, Michele GD et al. A wide variety of mutations in the parkin gene are responsible for autosomal recessive parkinsonism in Europe. French Parkinson's Disease Genetics Study Group and the European Consortium on Genetic Susceptibility in Parkinson's Disease. Hum Mol Genet 1999; 8: 567-574
41. Wang K, Gross A, Waksman G, Korsmeyer SJ. Mutagenesis of the BH3 domain of BAX identifies residues critical for dimerization and killing. Mol Cell Biol 1998; 18: 6083-6089
42. Trempe JF, Sauve V, Grenier K, Seirafi M, Tang MY, Menade M et al. Structure of parkin reveals mechanisms for ubiquitin ligase activation. Science 2013; 340: 1451-1455
43. Wauer T, Komander D. Structure of the human Parkin ligase domain in an autoinhibited state. EMBO J 2013; 32: 2099-2112
44. Riley BE, Lougheed JC, Callaway K, Velasquez M, Brecht E, Nguyen L et al. Structure and function of Parkin E3 ubiquitin ligase reveals aspects of RING and HECT ligases. Nat Commun 2013; 4: 1982
45. Suzuki M, Youle RJ, Tjandra N. Structure of Bax: coregulation of dimer formation and intracellular localization. Cell 2000; 103: 645-654
46. Cartron PF, Moreau C, Oliver L, Mayat E, Meflah K, Vallette FM. Involvement of the N-terminus of Bax in its intracellular localization and function. FEBS Lett 2002; 512: 95-100
47. Czabotar PE, Lee EF, Thompson GV, Wardak AZ, Fairlie WD, Colman PM. Mutation to Bax beyond the BH3 domain disrupts interactions with pro-survival proteins and promotes apoptosis. J Biol Chem 2011; 286: 7123-7131
48. Goping IS, Gross A, Lavoie JN, Nguyen M, Jemmerson R, Roth K et al. Regulated targeting of BAX to mitochondria. J Cell Biol 1998; 143: 207-215
49. Hardwick JM, Soane L. Multiple functions of BCL-2 family proteins. Cold Spring Harb Perspect Biol 2013; 5: 2
50. Boohaker RJ, Zhang G, Carlson AL, Nemec KN, Khaled AR. BAX supports the mitochondrial network, promoting bioenergetics in nonapoptotic cells. Am J Physiol Cell Physiol 2011; 300: C1466-C1478
51. Jiao S, Li Z. Nonapoptotic function of BAD and BAX in long-term depression of synaptic transmission. Neuron 2011; 70: 758-772
52. Benard G, Neutzner A, Peng G, Wang C, Livak F, Youle RJ et al. IBRDC2, an IBR-type E3 ubiquitin ligase, is a regulatory factor for Bax and apoptosis activation. EMBO J 2010; 29: 1458-1471
53. Levy OA, Malagelada C, Greene LA. Cell death pathways in Parkinson's disease: proximal triggers, distal effectors, and final steps. Apoptosis 2009; 14: 478-500
54. Tatton NA. Increased caspase 3 and Bax immunoreactivity accompany nuclear GAPDH translocation and neuronal apoptosis in Parkinson's disease. Exp Neurol 2000; 166: 29-43
55. Wullner U, Kornhuber J, Weller M, Schulz JB, Loschmann PA, Riederer P et al. Cell death and apoptosis regulating proteins in Parkinson's disease-a cautionary note. Acta Neuropathol 1999; 97: 408-412
56. Horowitz JM, Pastor DM, Goyal A, Kar S, Ramdeen N, Hallas BH et al. BAX proteinimmunoreactivity in midbrain neurons of Parkinson's disease patients. Brain Res Bull 2003; 62: 55-61
57. Perier C, Bove J, Wu DC, Dehay B, Choi DK, Jackson-Lewis V et al. Two molecular pathways initiate mitochondria-dependent dopaminergic neurodegeneration in experimental Parkinson's disease. Proc Natl Acad Sci USA 2007; 104: 8161-8166
58. Vila M, Jackson-Lewis V, Vukosavic S, Djaldetti R, Liberatore G, Offen D et al. Bax ablation prevents dopaminergic neurodegeneration in the 1-methyl- 4-phenyl-1,2,3,6- tetrahydropyridine mouse model of Parkinson's disease. Proc Natl Acad Sci USA 2001; 98: 2837-2842
59. Biswas SC, Ryu E, Park C, Malagelada C, Greene LA. Puma and p53 play required roles in death evoked in a cellular model of Parkinson disease. Neurochem Res 2005; 30: 839-845
60. Fei Q, McCormack AL, Di Monte DA, Ethell DW. Paraquat neurotoxicity is mediated by a Bak-dependent mechanism. J Biol Chem 2008; 283: 3357-3364
61. Wilhelm M, Xu Z, Kukekov NV, Gire S, Greene LA. Proapoptotic Nix activates the JNK pathway by interacting with POSH and mediates death in a Parkinson disease model. J Biol Chem 2007; 282: 1288-1295
62. Jin SM, Youle RJ. PINK1- and Parkin-mediated mitophagy at a glance. J Cell Sci 2012; 125(Pt 4): 795-799
63. Rakovic A, Shurkewitsch K, Seibler P, Grunewald A, Zanon A, Hagenah J et al. PTEN-induced putative kinase 1 (PINK1)-dependent ubiquitination of endogenous Parkin attenuates mitophagy: study in human primary fibroblasts and induced pluripotent stem (iPS) cell-derived neurons. J Biol Chem 2012; 288: 2223-2237
64. Goslin K, Banker G. Culturing Nerve Cells, 1996. The MIT Press: Cambridge, MA, USA
65. Saura J, Tusell JM, Serratosa J. High-yield isolation of murine microglia by mild trypsinization. Glia 2003; 44: 183-189